Identification of novel transcription factors in osteoclast differentiation using genome-wide analysis of open chromatin determined by dnase-seq

Journal of Bone and Mineral Research

Volumn 29, Issue 8, 2014, Pages 1823-1832

  Inoue, Kazuki ^a,b   Imai, Yuuki ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b EHIME UNIVERSITY   (Japan)

Author keywords

Dnase sequence; Epigenetics; Osteoclast Differentiation; Osteoclasts; Transcription Factors

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 1; ACTIVATING TRANSCRIPTION FACTOR 2; ACTIVATING TRANSCRIPTION FACTOR 4; CATHEPSIN K; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DEOXYRIBONUCLEASE I; DNA FRAGMENT; NUCLEAR FACTOR OF ACTIVATED T CELLS CALCINEURIN DEPENDENT 1; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN FOS; SMALL INTERFERING RNA; SPACER DNA; SREBF2 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NRF1; UNCLASSIFIED DRUG; ZSCAN10 PROTEIN; CHROMATIN;

5' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BIOINFORMATICS; CHROMATIN; CHROMATIN STRUCTURE; CONTROLLED STUDY; DEOXYRIBONUCLEASE I HYPERSENSITIVE SITE; DNA SEQUENCE; ELECTROPORATION; EPIGENETICS; EXON; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE SEQUENCE; GENE SILENCING; GENETIC ASSOCIATION; INSULATOR ELEMENT; INTRON; MOUSE; NONHUMAN; NUCLEOSOME; OSTEOCLAST; OSTEOCLASTOGENESIS; PROMOTER REGION; REGULATOR GENE; RNA INTERFERENCE; ANIMAL; CELL DIFFERENTIATION; CELL LINE; CHROMOSOME MAP; CYTOLOGY; GENETICS; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CHROMATIN; CHROMOSOME MAPPING; GENOME-WIDE ASSOCIATION STUDY; MICE; OSTEOCLASTS; POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84904689151     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2229     Document Type: Article

References (40)

1. Martin TJ, Sims NA., Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med. 2005 Feb; 11 (2): 76-81.
2. Teitelbaum SL., Bone resorption by osteoclasts. Science. 2000 Sep 1; 289 (5484): 1504-8.
3. Teitelbaum SL, Ross FP., Genetic regulation of osteoclast development and function. Nat Rev Genet. 2003 Aug; 4 (8): 638-49.
4. Tondravi MM, McKercher SR, Anderson K, et al. Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. Nature. 1997 Mar 6; 386 (6620): 81-4.
5. Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R., Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med. 1997 Nov; 3 (11): 1285-9.
6. Grigoriadis AE, Wang ZQ, Cecchini MG, et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science. 1994 Oct 21; 266 (5184): 443-8.
7. Ikeda F, Nishimura R, Matsubara T, et al. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J Clin Invest. 2004 Aug; 114 (4): 475-84.
8. Takayanagi H, Kim S, Koga T, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002 Dec; 3 (6): 889-901.
9. Drake FH, Dodds RA, James IE, et al. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem. 1996 May 24; 271 (21): 12511-6.
10. Kim N, Takami M, Rho J, Josien R, Choi Y., A novel member of the leukocyte receptor complex regulates osteoclast differentiation. J Exp Med. 2002 Jan 21; 195 (2): 201-9.
11. Yagi M, Miyamoto T, Sawatani Y, et al. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med. 2005 Aug 1; 202 (3): 345-51.
12. Lee SH, Rho J, Jeong D, et al. v-ATPase V0 subunit d2-deficient mice exhibit impaired osteoclast fusion and increased bone formation. Nat Med. 2006 Dec; 12 (12): 1403-9.
13. Kouzarides T., Chromatin modifications and their function. Cell. 2007 Feb 23; 128 (4): 693-705.
14. Meissner A., Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol. 2010 Oct; 28 (10): 1079-88.
15. Yasui T, Hirose J, Tsutsumi S, Nakamura K, Aburatani H, Tanaka S., Epigenetic regulation of osteoclast differentiation: possible involvement of Jmjd3 in the histone demethylation of Nfatc1. J Bone Miner Res. 2011 Nov; 26 (11): 2665-71.
16. Felsenfeld G, Boyes J, Chung J, Clark D, Studitsky V., Chromatin structure and gene expression. Proc Natl Acad Sci USA. 1996 Sep 3; 93 (18): 9384-8.
17. Hesselberth JR, Chen X, Zhang Z, et al. Global mapping of protein-DNA interactions in vivo by digital genomic footprinting. Nat Methods. 2009 Apr; 6 (4): 283-9.
18. John S, Sabo PJ, Thurman RE, et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nat Genet. 2011 Mar; 43 (3): 264-8.
19. Thurman RE, Rynes E, Humbert R, et al. The accessible chromatin landscape of the human genome. Nature. 2012 Sep 6; 489 (7414): 75-82.
20. Song L, Zhang Z, Grasfeder LL, et al. Open chromatin defined by DNaseI and FAIRE identifies regulatory elements that shape cell-type identity. Genome Res. 2011 Oct; 21 (10): 1757-67.
21. He HH, Meyer CA, Chen MW, Jordan VC, Brown M, Liu XS., Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics. Genome Res. 2012 Jun; 22 (6): 1015-25.
22. Ling G, Sugathan A, Mazor T, Fraenkel E, Waxman DJ., Unbiased, genome-wide in vivo mapping of transcriptional regulatory elements reveals sex differences in chromatin structure associated with sex-specific liver gene expression. Mol Cell Biol. 2010 Dec; 30 (23): 5531-44.
23. Langmead B, Salzberg SL., Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012 Apr; 9 (4): 357-9.
24. Zhang Y, Liu T, Meyer CA, et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 2008; 9 (9): R137.
25. Robinson JT, Thorvaldsdottir H, Winckler W, et al. Integrative genomics viewer. Nat Biotechnol. 2011 Jan; 29 (1): 24-6.
26. Shin H, Liu T, Manrai AK, Liu XS., CEAS: cis-regulatory element annotation system. Bioinformatics. 2009 Oct 1; 25 (19): 2605-6.
27. He HH, Meyer CA, Shin H, et al. Nucleosome dynamics define transcriptional enhancers. Nat Genet. 2010 Apr; 42 (4): 343-7.
28. Gross DS, Garrard WT., Nuclease hypersensitive sites in chromatin. Ann Rev Biochem. 1988; 57: 159-97.
29. Zhao B, Takami M, Yamada A, et al. Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis. Nat Med. 2009 Sep; 15 (9): 1066-71.
30. Sato K, Suematsu A, Nakashima T, et al. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med. 2006 Dec; 12 (12): 1410-6.
31. Li X, Udagawa N, Itoh K, et al. p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology. 2002 Aug; 143 (8): 3105-13.
32. Cao H, Yu S, Yao Z, et al. Activating transcription factor 4 regulates osteoclast differentiation in mice. J Clin Invest. 2010 Aug; 120 (8): 2755-66.
33. Mikkelsen TS, Xu Z, Zhang X, et al. Comparative epigenomic analysis of murine and human adipogenesis. Cell. 2010 Oct 1; 143 (1): 156-69.
34. Asp P, Blum R, Vethantham V, et al. Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proc Natl Acad Sci USA. 2011 May 31; 108 (22): E149-58.
35. Zhang J, Parvin J, Huang K., Redistribution of H3K4me2 on neural tissue specific genes during mouse brain development. BMC Genomics. 2012; 13 (Suppl 8): S5.
36. Youn MY, Yokoyama A, Fujiyama-Nakamura S, et al. JMJD5, a Jumonji C (JmjC) domain-containing protein, negatively regulates osteoclastogenesis by facilitating NFATc1 protein degradation. J Biol Chem. 2012 Apr 13; 287 (16): 12994-3004.
37. Stitzel ML, Sethupathy P, Pearson DS, et al. Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab. 2010 Nov 3; 12 (5): 443-55.
38. Samstein RM, Arvey A, Josefowicz SZ, et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell. 2012 Sep 28; 151 (1): 153-66.
39. Youn MY, Takada I, Imai Y, Yasuda H, Kato S., Transcriptionally active nuclei are selective in mature multinucleated osteoclasts. Genes Cells. 2010 Oct; 15 (10): 1025-35.
40. Miyazaki M, Fujikawa Y, Takita C, Tsumura H., Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis. Clin Rheumatol. 2007 Feb; 26 (2): 231-9.